BAT releases fibroblast growth factor 21 (FGF21), a peptide hormone that can alleviate obesity and diabetes in animal experiments [23–25], and which increases insulin sensitivity and reduces gluconeogenesis in the liver [26–30]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.